or
forgot password
  • cancer clinical trials in montclair, NJ

  • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Mountainside Hospital Cancer Center
    Montclair, New Jersey 07042
    Breast Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Mountainside Hospital Cancer Center
    Montclair, New Jersey 07042
    Lymphoma
    Anastrozole & ZD1839 Compared With Fulvestrant & ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
    Mountainside Hospital Cancer Center
    Montclair, New Jersey 07042
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Cancer Center at the Mountainside Hospital
    Montclair, New Jersey 07042
    Kidney Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Mountainside Hospital
    Montclair, New Jersey 07042
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Mountainside Hospital
    Montclair, New Jersey 07042
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Mountainside Hospital
    Montclair, New Jersey 07042
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Promoting Physical Activity In After-School Programs for Urban Adolescents
    Health and Nutrition Sciences at Montclair State University
    Montclair, New Jersey 07043
    Unspecified Adult Solid Tumor, Protocol Specific
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Mountainside Hospital
    Montclair, New Jersey 07042
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Mountainside Hospital
    Montclair, New Jersey 07042
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
    Mountainside Hospital Cancer Center - The Melanoma Center
    Montclair, New Jersey 07042
    Melanoma
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    Mountainside Hospital
    Montclair, New Jersey 07042
    Melanoma
    Hydroxychloroquine + Carboplatin, Paclitaxel and Bevacizumb in Non-Small Cell Lung Cancer (NSCLC)
    Mountainside Hospital
    Montclair, New Jersey 07042
    Non-small Cell Lung Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Cancer Center at the Mountainside Hospital
    Montclair, New Jersey 07042
    Anal Cancer
    Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
    Mountainside Hospital Cancer Center
    Montclair, New Jersey 07042
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
    Mountainside Hospital Cancer Center
    Montclair, New Jersey 07042
    Breast Cancer
    Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
    Mountainside Hospital Cancer Center
    Montclair, New Jersey 07042
    Breast Cancer
    Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Mountainside Hospital Cancer Center
    Montclair, New Jersey 07042
    Lung Cancer
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    Mountainside Hospital Cancer Center
    Montclair, New Jersey 07042
    Breast Cancer
    Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
    Cancer Center at the Mountainside Hospital
    Montclair, New Jersey 07042
    Carcinoma of Unknown Primary
    Etoposide and Cyclophosphamide in Treating Patients With Stage D0 Prostate Cancer
    Mountainside Hospital Cancer Center
    Montclair, New Jersey 07042
    Prostate Cancer
    A Study of OncoVEXGM-CSF in Stage IIIc and Stage IV Malignant Melanoma
    Mountainside Hospital
    Montclair, New Jersey 07042
    Melanoma
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Mountainside Hospital
    Montclair, New Jersey 07042
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
    Atlantic Health Research - Mountainside Hospital
    Montclair, New Jersey 07042
    Melanoma
    Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer
    Mountainside Hospital
    Montclair, New Jersey 07042
    Prostate Cancer